Navigation Links
As Pharmaceutical Deal Making Becomes More Competitive, PharmaDeals(R) Resource Expands its Deal Coverage
Date:8/19/2010

As Pharmaceutical Deal Making Becomes More Competitive, PharmaDeals(R) Resource Expands its Deal... -- OXFORD, England, August 19, 2010 /PRNewswire/ --


Advanced Search Search

  
Close
  1. Send a release
  2. Member sign in
  3. Become a member
  4. For journalists
  5. Global sites
PR Newswire: news distribution, targeting and monitoring
  1. Products & Services
  2. Knowledge Center
  3. Browse News Releases
  4. Contact PR Newswire
Cosmetics and Personal Care, Health Care & Hospitals, Medical Equipment, Medical Pharmaceuticals, New Products & Services Click to view news release full screen  

As Pharmaceutical Deal Making Becomes More Competitive, PharmaDeals(R) Resource Expands its Deal Coverage

 

OXFORD, England, August 19, 2010 /PRNewswire/ -- PharmaVentures, the company behind the PharmaDeals(R) range of business information, announced today the expansion of its PharmaDeals Agreements coverage that includes exclusive interviews with deal makers around the world. The announcement follows major enhancement of its dedicated, market leading platform delivering deal data and information to the pharmaceutical and biotechnology sector.

The scope of PharmaDeals Agreements database has been expanded to include categories of deals that have medical and therapeutic applications in cosmetics, internet and e-commerce, nutritional supplements, packaging, wound care, bioterrorism, as well as deeper classifications within drug delivery technologies.

Fintan Walton, PhD, Chief Executive of PharmaVentures, says, "We are very excited about our latest version of PharmaDeals. One of the big issues that face those in researching and analysing deals is the lack of scope within databases they use which is a result of the huge changes taking place in the world of deal making. More companies are doing specialist deals, for example, with orphan drugs, and the world is changing as new technologies, mechanisms of action and even new therapy areas emerge. Frankly no one else has tried to come up with solutions to these changes."

New content is also being sourced related to deal making by Clinical Research and Contract Manufacturing Organizations. The development to the database augments recent improvements to the classifications and user interface.

As deal making is a people business subscribers can for the first time access exclusive television interviews with the key deal makers in the major pharmaceutical companies as well as key influencers at the corporate level such as CEOs and Board Members of corporations.

Dr Walton continues, "A key priority for us is to better serve our customers with information about deals from rapidly developing markets, and we have done this by considerably increasing our sources, especially in India, China, and generally within South Asia and South America. These developments to our content are additional key milestones for us, and, in the very near future, we shall be bringing news of further offerings to help our clients' ability to win the best deals for them."

Notes to Editors:

About PharmaVentures

PharmaVentures Limited (http://www.pharmaventures.com) is based in Oxford, England and is a leading international corporate advisory firm supporting its clients' growth ambitions through licensing, joint ventures and M&A in the healthcare industry. The company works for a variety of clients from start-ups to global pharmaceutical corporations, their advisors, investment companies and government bodies. It also produces the highly popular PharmaDeals(R) range of intelligence products including analysis tools and reports. In 2006, it launched the world's first dedicated online pharmaceutical television channel PharmaTelevision(R) ( http://www.pharmatelevision.com)

http://www.pharmaventures.com http://www.pharmadeals.net http://www.pharmatelevision.com PharmaDeals(R) is a registered Trade Mark of PharmaVentures Ltd.

For further information about PharmaDeals and other PharmaVentures products and services, including ordering, please contact:

Doug Cookson Commercial Director, PharmaVentures Magdalen Centre Oxford Science Park Oxfordshire OX4 4GA, UK T: +44(0)1865-332731 E: doug.cookson@pharmaventures.com
'/>"/>

SOURCE PharmaVentures
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Protectus Medical Devices Appoints as Medical Director a Physician Surgeon With 20-Year Involvement in Senior Level Monitoring of Pharmaceutical and Medical Devices
2. Optimer Pharmaceuticals Fidaxomicin Marketing Authorization Application Accepted for Review by European Medicines Agency
3. Quark Pharmaceuticals and Major Pharmaceutical Company Enter into Licensing Option Agreement for the p53 Suppressor Drug QPI-1002, the First siRNA Administered Systemically in Human
4. RedOak Logics Mission: Transform Pharmaceutical Industry Drug Development
5. Biostar Pharmaceuticals, Inc. Second Quarter Revenue Increased 46.4% to $19.4 Million
6. Decision Resources Competitive Landscape Seminar Series: Biologics and Biosimilars on September 14, 2010 Will Help Pharmaceutical Companies Understand Market Opportunities for Biologics and Biosimilars
7. Trubion Pharmaceuticals Inc. Reports Second-Quarter and First-Half 2010 Financial Results
8. Cumberland Pharmaceuticals Reports Second Quarter 2010 Financial Results
9. Ferring Pharmaceuticals FIRMAGON® Joins Race to End Prostate Cancer as Official Sponsor of the Great Prostate Cancer Challenge / Dash for Dad
10. Jiangbo Pharmaceuticals Announces the Commercial Launch of Felodipine Sustained Release Tablets
11. Reportlinker Adds Effective Social Media Marketing Strategies for Pharmaceutical Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical Systems ... "Company"), which develops, markets and sells medical devices and ... , signed a strategic cooperation agreement with Hongyuan Supply ... Supply Chain") on June 20, 2016, to develop Dehaier,s ... strategic cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
Breaking Medicine Technology:
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
(Date:6/24/2016)... ... June 24, 2016 , ... Those who have experienced ... feelings, many turn to unhealthy avenues, such as drug or alcohol abuse, as a ... has released tools for healthy coping following a traumatic event. , Trauma sufferers tend ...
(Date:6/24/2016)... Texas (PRWEB) , ... June 24, 2016 , ... ... International Conference and Scientific Sessions in Dallas that it will receive two significant ... of the grants came as PHA marked its 25th anniversary by recognizing patients, ...
(Date:6/24/2016)... ... 24, 2016 , ... Comfort Keepers® of San Diego, CA is excited to ... Recovery® program to drive cancer patients to and from their cancer treatments. Comfort ... quality of life and ongoing independence. Getting to and from medical treatments is ...
Breaking Medicine News(10 mins):